C12N 2840/50
Utilisation of non-atg initiation codon
Official title: utilisation of non-ATG initiation codon
C12N2840/50 (Utilisation of non-atg initiation codon) appears on 6 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 16
- Assignees
- 9
- Inventors
- 31
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 2 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 2 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Expression cassette for expressing gene comprising overlapping open reading frames in insect cell and application thereof18 Nov 2025US 12,473,571 B2Genveoyager (Wuhan) Co., Ltd.
- Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof24 Jul 2018US 10,030,252 B2Tapimmune, Inc.
- Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof5 Jun 2018US 9,988,643 B2Tapimmune, Inc.
- Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof23 May 2017US 9,655,956 B2Tapimmune, Inc.
- Chimeric nucleic acid molecule with non-AUG translation initiation sequences14 Jun 2016US 9,364,523 B2Tapimmune, Inc.
- Engineered polynucleotides for temporal control of expression5 Feb 2026US 2026/0035707 A1ModernaTX, Inc.
- Expression cassette for expressing gene comprising overlapping open reading frames in insect cell and application thereof25 Jul 2024US 2024/0247282 A1Genevoyager (Wuhan) Co., Ltd.
- Improved dependoparvovirus production compositions and methods9 Nov 2023US 2023/0357324 A1Dyno Therapeutics, Inc.
- Chimeric nucleic acid molecules with non-aug translation initiation sequences and uses thereof24 Feb 2022US 2022/0056473 A1Marker Therapeutics, Inc.
- Chimeric nucleic acid molecules with non-aug translation initiation sequences and uses thereof3 Feb 2022US 2022/0033844 A1Marker Therapeutics, Inc.
Most cited
By later US patents